Therapeutic comparison of flex seed and black seed supplementation for treatment of type II diabetic patients

Diabetes is one of the most prevailing global health issues. Genetic factors, obesity, environmental factors, poor dietary habits and sedentary life style are the main causes of its occurrence that leads to hyperglycemia and insulin resistance. In recent years therapeutic effects of dietary flaxseed and blackseed in management of diabetes has been studied. Both possess anti-oxidant, anti-hyperglycemic and anti-inflammatory properties. Secoisolariciresinol diglucoside (SDG) is a lignan present in flaxseed that lower the blood glucose level and fiber control insulin secretion and its mechanism of action. Thymoquinone (TQ) is a bioactive component present in flaxseed that control blood glucose level, insulin secretion and maintain glucose hemostasis. Both seeds are considered as highly acceptable with the great safety profile in management of type II diabetes. Therefore, this article highlights the therapeutic effects of flaxseed and blackseed supplementation in management of type II diabetes.